Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Simvastatin as a Biomarker for Intestinal Villous Health for Celiac Disease Patients
Robert Voyksner
ImmunogenX

DescriptionY/NSource
Grantsno
Salaryno
Board MemberyesBoard of directors of Flamentera AG, Advanced Telesensors, and Appellation Ventures
Stockyes ImmunogenX, Advanced Telesensors, Appellation Ventures, and some venture funds
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no